We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+12.98%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$95.4B
AUM Growth
+$9.26B
Cap. Flow
-$707M
Cap. Flow %
-0.74%
Top 10 Hldgs %
25.21%
Holding
4,380
New
32
Increased
1,513
Reduced
2,146
Closed
67

Top Buys

Rank Stock Value
1
IWB icon
iShares Russell 1000 ETF
IWB
+$99.9M
2
UBER icon
Uber
UBER
+$71M
3
AVGO icon
Broadcom
AVGO
+$36.2M
4
IWM icon
iShares Russell 2000 ETF
IWM
+$32.6M
5
LULU icon
lululemon athletica
LULU
+$32.3M

Top Sells

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$139M
2
AAPL icon
Apple
AAPL
+$72.7M
3
VMW
VMware, Inc
VMW
+$47.1M
4
SGEN
Seagen Inc. Common Stock
SGEN
+$42.3M
5
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$35.5M

Sector Composition

Rank Sector Weight
1 Technology 27.73%
2 Financials 13%
3 Healthcare 12.09%
4 Consumer Discretionary 11.32%
5 Industrials 9.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BZUN
3576
Baozun
BZUN
$172M
$5.27K ﹤0.01%
1,924
-2,079
-52% -$6.12K
CMRX
3577
DELISTED
Chimerix, Inc.
CMRX
$5.18K ﹤0.01%
5,391
– –
HYPR icon
3578
Hyperfine
HYPR
$101M
$5.14K ﹤0.01%
4,588
– –
SYRS
3579
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$5.13K ﹤0.01%
659
– –
BELFA icon
3580
Bel Fuse Inc Class A
BELFA
$3.37B
$5.13K ﹤0.01%
80
– –
QNRX
3581
Quoin Pharmaceuticals
QNRX
$9.62M
$5.13K ﹤0.01%
30
+4
+15% +$615
CXAI icon
3582
CXApp
CXAI
$17.5M
$5.13K ﹤0.01%
3,978
– –
CUK
3583
DELISTED
Carnival PLC
CUK
$5.13K ﹤0.01%
304
– –
ANTX icon
3584
AN2 Therapeutics
ANTX
$214M
$5.12K ﹤0.01%
250
– –
BVS icon
3585
Bioventus
BVS
$1.19B
$5.05K ﹤0.01%
959
– –
CONN
3586
DELISTED
Conn's Inc.
CONN
$5.02K ﹤0.01%
1,131
– –
ROOT icon
3587
Root
ROOT
$798M
$4.95K ﹤0.01%
472
– –
XYLO
3588
DELISTED
Xylo Technologies
XYLO
$4.88K ﹤0.01%
541
– –
DDL
3589
Dingdong
DDL
$503M
$4.87K ﹤0.01%
3,245
– –
RLMD icon
3590
Relmada Therapeutics
RLMD
$527M
$4.86K ﹤0.01%
1,174
– –
GRRR
3591
Gorilla Technology Group
GRRR
$365M
$4.69K ﹤0.01%
870
– –
ADAP
3592
DELISTED
Adaptimmune Therapeutics
ADAP
$4.69K ﹤0.01%
5,912
+330
+6% +$186
GP
3593
GreenPower Motor Co
GP
$11M
$4.68K ﹤0.01%
150
+93
+163% +$2.82K
LXEH
3594
Lixiang Education Holding
LXEH
$3.28M
$4.68K ﹤0.01%
22
– –
APEI icon
3595
American Public Education
APEI
$940M
$4.64K ﹤0.01%
481
– –
AOUT icon
3596
American Outdoor Brands
AOUT
$157M
$4.62K ﹤0.01%
550
– –
TDCX
3597
DELISTED
TDCX Inc. American Depositary Shares, each representing one Class A ordinary share
TDCX
$4.61K ﹤0.01%
950
+680
+252% +$3.34K
TCS
3598
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
$4.6K ﹤0.01%
135
– –
GAIA icon
3599
Gaia
GAIA
$48.4M
$4.59K ﹤0.01%
1,700
– –
AXTI icon
3600
AXT Inc
AXTI
$5.8B
$4.49K ﹤0.01%
1,871
– –
142 143
144
145 146

Similar funds

VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

RhumbLine Advisers's Q4 2023 Portfolio in Review

As of Q4 2023, RhumbLine Advisers held 4,380 positions worth $95.4B, up 11% from $86.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Trading was light in Q4 2023: portfolio turnover was 2.3%. RhumbLine Advisers opened 32 new positions and exited 67, leaving the 4,380-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q4 2023 buy was CRH: 83,048 shares worth $5.74M.
  • RhumbLine Advisers added most to iShares Russell 1000 ETF in Q4 2023, an estimated $99.9M increase.
  • RhumbLine Advisers's biggest Q4 2023 reduction was Apple, cutting an estimated $72.7M.
  • RhumbLine Advisers fully exited Activision Blizzard in Q4 2023, selling an estimated $139M.
  • RhumbLine Advisers's ten largest holdings make up 25% of its $95.4B portfolio in Q4 2023.
  • RhumbLine Advisers opened 32 new positions and closed 67 in Q4 2023.
  • RhumbLine Advisers's portfolio value rose 11% quarter-over-quarter to $95.4B.

Based on RhumbLine Advisers's 13F filing for Q4 2023, filed 8 Feb 2024.